美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Gyre Therapeutics

8.13

+0.33004.23%

盘后：8.130.00000.00%15:26 EDT

成交量：6.60万

成交额：52.56万

市值：7.80亿

市盈率：169.10

高：8.15

开：7.86

低：7.76

收：7.80

数据加载中...

总览公司新闻资讯公告

Gyre Therapeutics(GYRE.US)：2024年Q4财报实现营收2787.2万美元，前值为2714.8万美元。

Gyre Therapeutics第四季度每股收益为0.00美元, 前值为$(1.39); 销售额为2787万美元, 前值为2715万美元

Gyre Therapeutics, Inc.盘中异动早盘大幅上涨6.87%

Gyre Therapeutics, Inc.盘中异动快速跳水5.04%

Gyre Therapeutics, Inc.盘中异动早盘快速下挫5.03%

Gyre Therapeutics, Inc.盘中异动股价大跌5.30%报10.99美元

异动解读 | Gyre Therapeutics盘中大涨8.53% 疗效数据或成利好驱动因素

Gyre Therapeutics, Inc.盘中异动早盘急速上涨5.50%报11.13美元

Gyre Therapeutics, Inc.盘中异动早盘急速跳水5.37%

Gyre Therapeutics, Inc.盘中异动下午盘股价大跌5.02%报11.93美元

Gyre Therapeutics, Inc.盘中异动大幅拉升5.59%

Gyre Therapeutics, Inc.盘中异动下午盘急速下挫5.25%

Gyre Therapeutics, Inc.盘中异动下午盘急速上涨5.22%报12.50美元

Gyre Therapeutics, Inc.盘中异动快速上涨5.05%报11.14美元

Gyre Therapeutics, Inc.盘中异动早盘股价大涨5.11%

Gyre Therapeutics, Inc.盘中异动急速上涨6.97%

Gyre Therapeutics, Inc.盘中异动大幅上涨5.34%

Gyre Therapeutics, Inc.盘中异动快速下挫5.00%报10.25美元

Gyre Therapeutics, Inc.盘中异动快速下挫5.06%报12.02美元

Gyre Therapeutics, Inc.盘中异动下午盘股价大跌5.03%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/GYRE/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GYRE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GYRE\",,,,,undefined,":{"symbol":"GYRE","market":"US","secType":"STK","nameCN":"Gyre Therapeutics","latestPrice":8.13,"timestamp":1751562000000,"preClose":7.8,"halted":0,"volume":66013,"hourTrading":{"tag":"盘后","latestPrice":8.13,"preClose":8.13,"latestTime":"15:26 EDT","volume":60,"amount":487.52,"timestamp":1751570798943},"delay":0,"floatShares":25607700,"shares":95979800,"eps":0.048077,"marketStatus":"休市中","change":0.33,"latestTime":"07-03 13:00:00 EDT","open":7.86,"high":8.15,"low":7.755,"amount":525624.9044,"amplitude":0.050641,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.048077,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1751875200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":7.8,"postHourTrading":{"tag":"盘后","latestPrice":8.13,"preClose":8.13,"latestTime":"15:26 EDT","volume":60,"amount":487.52,"timestamp":1751570798943},"volumeRatio":0.34003961735220134,"impliedVol":1.0798,"impliedVolPercentile":0.7966},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GYRE\",,,,,undefined,":{"symbol":"GYRE","floatShares":25607700,"roa":"5.18%","roe":"12.12%","lyrEps":0.142017,"volumeRatio":0.34003961735220134,"shares":95979800,"dividePrice":0,"high":8.15,"amplitude":0.050641,"preClose":7.8,"low":7.755,"week52Low":6.11,"pbRate":"11.45","psRate":"7.75","week52High":19,"institutionHeld":0.0832,"latestPrice":8.13,"eps":0.048077,"divideRate":0,"volume":66013,"delay":0,"ttmEps":0.048077,"open":7.86,"prevYearClose":12.1,"prevWeekClose":7.42,"prevMonthClose":7.35,"prevQuarterClose":7.35,"fiveDayClose":7.38,"twentyDayClose":8.58,"sixtyDayClose":7.62},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GYRE\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520163870","title":"Gyre Therapeutics(GYRE.US)：2024年Q4财报实现营收2787.2万美元，前值为2714.8万美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2520163870","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520163870?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 07:04","pubTimestamp":1742252656,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics(GYRE.US)：2024年Q4财报实现营收2787.2万美元，前值为2714.8万美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/18070448811776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LENZ","GYRE"],"gpt_icon":0},{"id":"1122776621","title":"Gyre Therapeutics第四季度每股收益为0.00美元, 前值为$(1.39); 销售额为2787万美元, 前值为2715万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122776621","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122776621?lang=zh_cn&edition=fundamental","pubTime":"2025-03-18 04:23","pubTimestamp":1742242994,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics (NASDAQ:GYRE) 本季度报告销售额为2787万美元，与去年同期的销售额2715万美元相比增长了2.67%。以上内容来自Benzinga Earnings专栏，原文如下：$Gyre Therapeutics(GYRE)$ (NASDAQ:GYRE) reported $27.87 million in sales this quarter. This is a 2.67 percent increase over sales of $27.15 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Gyre Therapeutics第四季度每股收益为0.00美元, 前值为$(1.39); 销售额为2787万美元, 前值为2715万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GYRE"],"gpt_icon":0},{"id":"2518744514","title":"Gyre Therapeutics, Inc.盘中异动 早盘大幅上涨6.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518744514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518744514?lang=zh_cn&edition=fundamental","pubTime":"2025-03-11 21:34","pubTimestamp":1741700047,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日21时34分，Gyre Therapeutics, Inc.股票出现异动，股价快速上涨6.87%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.97%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311213407ab5de9e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311213407ab5de9e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","GYRE"],"gpt_icon":0},{"id":"2518278808","title":"Gyre Therapeutics, Inc.盘中异动 快速跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278808","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518278808?lang=zh_cn&edition=fundamental","pubTime":"2025-03-10 21:44","pubTimestamp":1741614262,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时44分，Gyre Therapeutics, Inc.股票出现波动，股价快速跳水5.04%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214423abf30134&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214423abf30134&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"2516367029","title":"Gyre Therapeutics, Inc.盘中异动 早盘快速下挫5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516367029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516367029?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 22:49","pubTimestamp":1741099741,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时49分，Gyre Therapeutics, Inc.股票出现异动，股价大幅跳水5.03%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224901abe7f54c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224901abe7f54c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2516652358","title":"Gyre Therapeutics, Inc.盘中异动 股价大跌5.30%报10.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516652358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516652358?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 02:33","pubTimestamp":1741026798,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时33分，Gyre Therapeutics, Inc.股票出现异动，股价急速下挫5.30%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023318abe6790c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304023318abe6790c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"1167510703","title":"异动解读 | Gyre Therapeutics盘中大涨8.53% 疗效数据或成利好驱动因素","url":"https://stock-news.laohu8.com/highlight/detail?id=1167510703","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167510703?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:47","pubTimestamp":1740494854,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics今日盘中大涨8.53%,引发市场关注。这家生物制药公司主攻治疗肝纤维化相关药物研发,近期可能有利好推动股价上涨。Gyre Therapeutics目前正在研发一种治疗多种慢性肝病肝纤维化的药物 Hydronidone。市场对该药物疗效数据充满期待,有助于推升公司股价。除了 Hydronidone 外,Gyre Therapeutics在中国地区还有多个在研管线药物,包括吡非尼酮、F573、F528 和 F230 等。丰富的产品管线有望为公司带来长期的增长动力。投资者对该公司长期发展前景抱有信心,股价自然受到提振。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | Gyre Therapeutics盘中大涨8.53% 疗效数据或成利好驱动因素","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GYRE"],"gpt_icon":0},{"id":"2514090616","title":"Gyre Therapeutics, Inc.盘中异动 早盘急速上涨5.50%报11.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514090616?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 22:32","pubTimestamp":1740493923,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时32分，Gyre Therapeutics, Inc.股票出现异动，股价急速上涨5.50%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223203a25386e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223203a25386e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2514477545","title":"Gyre Therapeutics, Inc.盘中异动 早盘急速跳水5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514477545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514477545?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 00:11","pubTimestamp":1740413509,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时11分，Gyre Therapeutics, Inc.股票出现异动，股价快速下跌5.37%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.13%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225001149abdb254f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225001149abdb254f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2513215200","title":"Gyre Therapeutics, Inc.盘中异动 下午盘股价大跌5.02%报11.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513215200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513215200?lang=zh_cn&edition=fundamental","pubTime":"2025-02-22 02:15","pubTimestamp":1740161710,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日02时15分，Gyre Therapeutics, Inc.股票出现异动，股价大幅下跌5.02%。截至发稿，该股报11.93美元/股，成交量3.3733万股，换手率0.04%，振幅6.21%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.39%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222021511abd7df24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222021511abd7df24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2512238166","title":"Gyre Therapeutics, Inc.盘中异动 大幅拉升5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512238166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512238166?lang=zh_cn&edition=fundamental","pubTime":"2025-02-18 22:34","pubTimestamp":1739889246,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时34分，Gyre Therapeutics, Inc.股票出现异动，股价急速上涨5.59%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223406962797aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223406962797aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2509177814","title":"Gyre Therapeutics, Inc.盘中异动 下午盘急速下挫5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509177814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509177814?lang=zh_cn&edition=fundamental","pubTime":"2025-02-08 02:58","pubTimestamp":1738954723,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时58分，Gyre Therapeutics, Inc.股票出现异动，股价急速跳水5.25%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.67%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208025843987dda7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208025843987dda7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2509237702","title":"Gyre Therapeutics, Inc.盘中异动 下午盘急速上涨5.22%报12.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509237702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509237702?lang=zh_cn&edition=fundamental","pubTime":"2025-02-06 02:36","pubTimestamp":1738780597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日02时36分，Gyre Therapeutics, Inc.股票出现波动，股价快速拉升5.22%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为2.23%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206023639987ba2b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206023639987ba2b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0},{"id":"2506894933","title":"Gyre Therapeutics, Inc.盘中异动 快速上涨5.05%报11.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506894933","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506894933?lang=zh_cn&edition=fundamental","pubTime":"2025-01-25 02:32","pubTimestamp":1737743526,"startTime":"0","endTime":"0","summary":"北京时间2025年01月25日02时32分，Gyre Therapeutics, Inc.股票出现波动，股价快速上涨5.05%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125023206a22e8d62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250125023206a22e8d62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2503774571","title":"Gyre Therapeutics, Inc.盘中异动 早盘股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503774571","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503774571?lang=zh_cn&edition=fundamental","pubTime":"2025-01-14 22:41","pubTimestamp":1736865717,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时41分，Gyre Therapeutics, Inc.股票出现异动，股价快速上涨5.11%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114224158abaaaf5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114224158abaaaf5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2502864743","title":"Gyre Therapeutics, Inc.盘中异动 急速上涨6.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502864743","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502864743?lang=zh_cn&edition=fundamental","pubTime":"2025-01-10 22:32","pubTimestamp":1736519528,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时32分，Gyre Therapeutics, Inc.股票出现异动，股价急速上涨6.97%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.83%。其相关个股中，Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.、Zyversa Therapeutics, Inc.涨幅较大，Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.、Precision Biosciences, Inc.较为活跃，换手率分别为901.72%、131.67%、105.87%，振幅较大的相关个股有Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为15.25%、10.00%、8.90%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102232089861e7b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501102232089861e7b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2501788548","title":"Gyre Therapeutics, Inc.盘中异动 大幅上涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501788548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501788548?lang=zh_cn&edition=fundamental","pubTime":"2025-01-07 22:44","pubTimestamp":1736261061,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日22时44分，Gyre Therapeutics, Inc.股票出现波动，股价急速拉升5.34%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224421a218ea7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107224421a218ea7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2501255121","title":"Gyre Therapeutics, Inc.盘中异动 快速下挫5.00%报10.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2501255121","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501255121?lang=zh_cn&edition=fundamental","pubTime":"2025-01-06 23:01","pubTimestamp":1736175699,"startTime":"0","endTime":"0","summary":"北京时间2025年01月06日23时01分，Gyre Therapeutics, Inc.股票出现异动，股价急速下跌5.00%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106230139985ced98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250106230139985ced98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","LENZ","BK4139"],"gpt_icon":0},{"id":"2500364252","title":"Gyre Therapeutics, Inc.盘中异动 快速下挫5.06%报12.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500364252","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500364252?lang=zh_cn&edition=fundamental","pubTime":"2025-01-01 04:14","pubTimestamp":1735676044,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日04时14分，Gyre Therapeutics, Inc.股票出现波动，股价急速下跌5.06%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101041405a210ca79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101041405a210ca79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GYRE","BK4139","LENZ"],"gpt_icon":0},{"id":"2494336722","title":"Gyre Therapeutics, Inc.盘中异动 下午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2494336722","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494336722?lang=zh_cn&edition=fundamental","pubTime":"2024-12-28 02:14","pubTimestamp":1735323267,"startTime":"0","endTime":"0","summary":"北京时间2024年12月28日02时14分，Gyre Therapeutics, Inc.股票出现异动，股价快速下跌5.03%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.58%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家总部位于加利福尼亚州圣迭戈的生物制药公司，主要致力于 Hydronidone  的开发和商业化，该药物被用于治疗代谢功能障碍相关的脂肪性肝炎（MASH 相关肝纤维化（MASH 纤维化），以前在美国被称为非酒精性脂肪性肝炎（NASH）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228021427ab951d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241228021427ab951d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GYRE","LENZ"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GYRE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-09","symbol":"GYRE","fiscalQuarterEnding":"2025/03","expectedEps":0.03,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2025-03-17","symbol":"GYRE","fiscalQuarterEnding":"2024/12","expectedEps":0.04,"name":null,"time":"盘后","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":0.01},{"date":"2025-02-18","symbol":"GYRE","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739869200000,"name":null,"time":"盘前","dateTimestamp":1739854800000,"actualEps":null},{"market":"US","date":"2024-11-13","symbol":"GYRE","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"pre","actualEps":0.02},{"market":"US","date":"2024-08-13","symbol":"GYRE","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GYRE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GYRE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1741752000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GYRE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GYRE","date":"2025-07-03","current":101.646411,"percent":0.925926,"low":-11548.718266,"twenty":-26.790554,"median":-11.75017,"eighty":66.71,"high":139.727206,"avg":-1138.764578,"sd":3077.119065,"marketCap":737038125},"quantilePoints":[{"date":"2024-04-05","current":-15.607876,"twenty":-15.830217,"median":-15.617068,"eighty":-15.398378,"marketCap":1450486717},{"date":"2024-04-12","current":-31.76291,"twenty":-32.589325,"median":-21.429161,"eighty":-15.61523,"marketCap":1405212396},{"date":"2024-04-19","current":-29.754799,"twenty":-32.477335,"median":-30.585076,"eighty":-15.742078,"marketCap":1316372220},{"date":"2024-04-26","current":-31.531205,"twenty":-31.948274,"median":-30.797472,"eighty":-16.000876,"marketCap":1394961607},{"date":"2024-05-03","current":-27.239192,"twenty":-31.948274,"median":-30.778163,"eighty":-24.631989,"marketCap":1205080075},{"date":"2024-05-10","current":-14.851474,"twenty":-31.774495,"median":-30.223912,"eighty":-24.631989,"marketCap":1301657414},{"date":"2024-05-17","current":-14.909982,"twenty":-31.744918,"median":-29.754799,"eighty":-15.561911,"marketCap":1306785414},{"date":"2024-05-24","current":-12.302842,"twenty":-31.573048,"median":-28.630129,"eighty":-14.89828,"marketCap":1078282562},{"date":"2024-05-31","current":-8605.737804,"twenty":-32.075712,"median":-29.501562,"eighty":-15.108912,"marketCap":890160307},{"date":"2024-06-07","current":-8895.075775,"twenty":-32.90985,"median":-30.136978,"eighty":-15.311743,"marketCap":920088848},{"date":"2024-06-14","current":-9126.546144,"twenty":-8519.763095,"median":-30.585076,"eighty":-15.366351,"marketCap":944031680},{"date":"2024-06-21","current":-8961.210165,"twenty":-8885.155616,"median":-30.816781,"eighty":-15.424018,"marketCap":926929657},{"date":"2024-06-28","current":-8175.864257,"twenty":-8865.315298,"median":-30.894016,"eighty":-15.515947,"marketCap":845695047},{"date":"2024-07-05","current":-9688.68848,"twenty":-8961.210165,"median":-31.531205,"eighty":-15.611553,"marketCap":1002178559},{"date":"2024-07-12","current":-10424.433593,"twenty":-9151.346542,"median":-31.791873,"eighty":-15.679573,"marketCap":1078282562},{"date":"2024-07-15","current":-11094.044316,"twenty":-9210.867496,"median":-31.820836,"eighty":-15.710825,"marketCap":1147545756},{"date":"2024-08-02","current":-11548.718266,"twenty":-9298.495565,"median":-32.139431,"eighty":-15.742078,"marketCap":1194576320},{"date":"2024-08-09","current":-8374.267436,"twenty":-9189.373818,"median":-32.728348,"eighty":-16.000876,"marketCap":866217475},{"date":"2024-08-16","current":-10.635127,"twenty":-9134.812943,"median":-32.641458,"eighty":-15.61523,"marketCap":914301855},{"date":"2024-08-23","current":-11.421808,"twenty":-9126.546144,"median":-31.820836,"eighty":-15.175222,"marketCap":981932798},{"date":"2024-08-30","current":-13.672312,"twenty":-9020.73112,"median":-31.635813,"eighty":-14.375603,"marketCap":1175408659},{"date":"2024-09-06","current":-11.770337,"twenty":-8974.437045,"median":-30.942288,"eighty":-13.816505,"marketCap":1011895874},{"date":"2024-09-13","current":-14.920484,"twenty":-8961.210165,"median":-30.778163,"eighty":-13.696211,"marketCap":1282714046},{"date":"2024-09-20","current":-15.572509,"twenty":-8941.369845,"median":-30.223912,"eighty":-13.816505,"marketCap":1338768556},{"date":"2024-09-27","current":-13.909847,"twenty":-8923.182886,"median":-29.754799,"eighty":-13.90034,"marketCap":1195829555},{"date":"2024-10-04","current":-13.312158,"twenty":-8919.876167,"median":-28.630129,"eighty":-13.654308,"marketCap":1144446254},{"date":"2024-10-11","current":-12.327984,"twenty":-8904.995932,"median":-26.800559,"eighty":-13.325198,"marketCap":1059836795},{"date":"2024-10-18","current":-15.235629,"twenty":-8865.315298,"median":-15.915547,"eighty":-13.300875,"marketCap":1309807059},{"date":"2024-10-25","current":-15.300832,"twenty":-8830.594739,"median":-15.607876,"eighty":-13.325198,"marketCap":1315412510},{"date":"2024-10-31","current":-15.985457,"twenty":-8804.140979,"median":-15.617068,"eighty":-13.405529,"marketCap":1374269746},{"date":"2024-11-08","current":-16.365804,"twenty":-8779.340581,"median":-15.748988,"eighty":-13.558712,"marketCap":1406968211},{"date":"2024-11-15","current":-13.372591,"twenty":-8709.89947,"median":-15.77333,"eighty":-13.558712,"marketCap":1187780244},{"date":"2024-11-22","current":-11.353175,"twenty":-8602.431085,"median":-15.627389,"eighty":-13.295234,"marketCap":1008411696},{"date":"2024-11-29","current":-12.087508,"twenty":-8556.137012,"median":-15.590193,"eighty":-13.126615,"marketCap":1073636622},{"date":"2024-12-06","current":-10.111572,"twenty":-8387.494312,"median":-15.378053,"eighty":-12.781935,"marketCap":898130076},{"date":"2024-12-13","current":-9.449706,"twenty":-8374.267436,"median":-15.329691,"eighty":-12.475931,"marketCap":839341820},{"date":"2024-12-20","current":-10.299987,"twenty":-8344.506959,"median":-15.279098,"eighty":-12.329976,"marketCap":914865419},{"date":"2024-12-27","current":-12.686569,"twenty":-8225.465052,"median":-15.246496,"eighty":-12.302842,"marketCap":1126846431},{"date":"2025-01-03","current":-11.594732,"twenty":-8192.397854,"median":-15.235629,"eighty":-12.152426,"marketCap":1029867264},{"date":"2025-01-10","current":-9.29511,"twenty":-8179.170976,"median":-15.105225,"eighty":-11.98162,"marketCap":825610256},{"date":"2025-01-17","current":-10.435259,"twenty":-3290.168076,"median":-14.953086,"eighty":-11.68749,"marketCap":926880537},{"date":"2025-01-24","current":-10.242013,"twenty":-32.95233,"median":-14.893499,"eighty":-11.536758,"marketCap":909716083},{"date":"2025-01-31","current":-11.111618,"twenty":-32.786274,"median":-14.681409,"eighty":-11.380628,"marketCap":986956128},{"date":"2025-02-07","current":-12.319402,"twenty":-32.658836,"median":-14.539395,"eighty":-11.347378,"marketCap":1094233968},{"date":"2025-02-14","current":-11.382162,"twenty":-32.515952,"median":-14.451664,"eighty":-11.279742,"marketCap":1010986364},{"date":"2025-02-21","current":-12.135819,"twenty":-32.330588,"median":-14.072853,"eighty":-11.345445,"marketCap":1077927736},{"date":"2025-02-28","current":-10.90871,"twenty":-31.809251,"median":-13.976035,"eighty":-11.179254,"marketCap":968933450},{"date":"2025-03-07","current":-10.338636,"twenty":-31.758412,"median":-13.909847,"eighty":-11.12128,"marketCap":918298310},{"date":"2025-03-14","current":-11.556083,"twenty":-31.698577,"median":-13.789262,"eighty":-11.11355,"marketCap":1026434373},{"date":"2025-03-21","current":79.165838,"twenty":-31.423076,"median":-13.627303,"eighty":-11.045914,"marketCap":956719157},{"date":"2025-03-28","current":70.412668,"twenty":-30.971251,"median":-13.353241,"eighty":-10.90871,"marketCap":850937097},{"date":"2025-04-04","current":52.673943,"twenty":-30.878569,"median":-13.283951,"eighty":-10.748316,"marketCap":636564605},{"date":"2025-04-11","current":56.469566,"twenty":-30.809057,"median":-13.129602,"eighty":-10.622099,"marketCap":682434702},{"date":"2025-04-17","current":61.504575,"twenty":-30.778163,"median":-12.849861,"eighty":-10.560868,"marketCap":743282789},{"date":"2025-04-25","current":70.645053,"twenty":-30.585076,"median":-12.780906,"eighty":-10.377285,"marketCap":853745471},{"date":"2025-05-02","current":72.449806,"twenty":-30.310846,"median":-12.626921,"eighty":-10.338636,"marketCap":875555902},{"date":"2025-05-09","current":73.535777,"twenty":-30.136978,"median":-12.473999,"eighty":-10.164715,"marketCap":888679866},{"date":"2025-05-16","current":132.923099,"twenty":-29.947887,"median":-12.417259,"eighty":-9.938068,"marketCap":963825388},{"date":"2025-05-23","current":136.20365,"twenty":-29.754799,"median":-12.327984,"eighty":-9.652614,"marketCap":987612669},{"date":"2025-05-30","current":117.840031,"twenty":-29.349619,"median":-12.308068,"eighty":-9.440044,"marketCap":854458067},{"date":"2025-06-06","current":99.64599,"twenty":-28.753768,"median":-12.251767,"eighty":50.257139,"marketCap":722533070},{"date":"2025-06-13","current":100.896253,"twenty":-28.630129,"median":-12.168656,"eighty":56.159719,"marketCap":731598729},{"date":"2025-06-20","current":104.146938,"twenty":-27.795567,"median":-12.087508,"eighty":59.335648,"marketCap":755169444},{"date":"2025-06-27","current":92.269436,"twenty":-26.976012,"median":-11.969641,"eighty":62.92987,"marketCap":669045678},{"date":"2025-07-03","current":101.646411,"twenty":-26.790554,"median":-11.75017,"eighty":66.71,"marketCap":737038125}],"updateTime":1751732015588}}}